Januxrx
Executive Director, Process Development & Manufacturing
As a senior leader within the CMC organization, the Executive Director, Process Development & Manufacturing will provide strategic and technical leadership for the development, scale-up, technology transfer, and clinical manufacturing of Janux therapeutic candidates to advance the company’s pipeline
Executive Director, Process Development & Manufacturing
Senior/Executive Director, Translational Systems Immunology
Janux Therapeutics is seeking a scientifically rigorous, hands-on leader in Translational Systems Immunology to lead immunology strategy and generate key insights for the company's expanding Adaptive Immune Response Modulator (ARM) platform. This role will connect deep T-cell and B-cell biology with
Senior/Executive Director, Translational Systems Immunology
Vice President, Investor Relations & Corporate Communications
Janux Therapeutics is seeking a seasoned and strategic Vice President of Investor Relations & Corporate Communications to lead the company’s external engagement across the investment community, media, and broader public audiences. This role is instrumental in shaping Janux’s corporate narrative and
Vice President, Investor Relations & Corporate Communications
Manager, Clinical Supply Chain (Ancillary Supplies)
The Manager of Ancillary Supplies oversees the planning, sourcing, forecasting, and global distribution of non-investigational dosing supplies required to conduct clinical trials. This role is critical to ensuring investigational products can be administered safely and consistently across global cli
HR & Talent Coordinator
Janux Therapeutics is seeking an HR & Talent Coordinator to support a wide range of Human Resources and Talent Acquisition activities. This role is at the center of the employee experience, helping create a seamless journey from candidate interviews through onboarding and beyond. We are looking for
Clinical Trial Associate
The Clinical Trial Associate (CTA) will provide operational support for the planning, execution, and closeout of clinical studies across Janux Therapeutics' clinical development programs. The CTA will partner closely with Clinical Trial Managers, Clinical Operations leadership, CROs, study vendors,
Clinical Trial Associate
Senior Manager, Clinical Contracts
The Senior Manager, Clinical Contracts will ensure the successful negotiation and ongoing management of clinical trial-related agreements and serve as the key liaison between Clinical Operations, Legal, Finance and Accounting departments. This role involves but is not limited to generating, reviewin
Senior Manager, Clinical Contracts
Senior Director, Clinical Supply Chain
Janux Therapeutics is seeking a Senior Director, Clinical Supply Chain will lead and execute Janux’s clinical supply strategy across Phase 1–3 programs, with a focus on enabling progression into late-stage development. This is a hands-on leadership role responsible for ensuring uninterrupted global
Vice President, Clinical Operations (AID)
The Vice President of Clinical Operations will provide leadership for a clinical operations function and will be accountable for the operational strategy, execution, quality, and scalability of clinical programs supporting Janux’s innovative therapies across autoimmune indications. This executive wi
Vice President, Clinical Operations (AID)
Senior Director, Global Regulatory Affairs
The Senior Director, Global Regulatory Affairs will provide strategic regulatory leadership across Janux’s clinical-stage oncology pipeline, supporting programs from early development through registration. This individual will lead global regulatory strategy for one or more programs while influencin
Senior Director, Global Regulatory Affairs
Vice President / Senior Vice President, Clinical Development (AID)
The Vice President/Senior Vice President, Clinical Development will serve as the strategic clinical leader for Janux’s expanding autoimmune pipeline, driving the vision and execution of clinical development programs in autoimmune diseases. This leader, reporting to the CEO, will shape the company’s